EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Latest
Circana: Fragrance demand expected to rise this holiday season
About one in five consumers purchased fragrance as a holiday gift last year, and purchase intentions are even higher this year.
Americans’ grocery carts score far below health benchmark
The FoodHealth Score assesses purchases based on nutrient density and ingredient quality.
Brian Wynne named chair of American Heart Association's 2026 First Coast Heart Ball
Heart Ball chairmanship centers on advocacy, access, and care for military families.
Facts up Front, SmartLabel gain recognition as transparency efforts grow
According to research from the Consumer Brands Association, 90% of Americans recognize Facts Up Front, and 22 million SmartLabel scans occur each year.